Herbalife Ltd. will transition Stephan Gratziani from his chief executive officer role effective October 31, 2026. For investors, the announcement establishes a specific date for the Leadership change and identifies the executive involved. Henry C. Wang signed on behalf of Herbalife Ltd. as chief legal officer and corporate secretary.
Key Highlights
- Herbalife Ltd. announced the leadership change on August 31, 2026.
- Henry C. Wang signed on behalf of Herbalife Ltd. as chief legal officer and corporate secretary.
- Stephan Gratziani is the executive transitioning from the chief executive officer role.
CEO Transition Takes Effect October 31
Stephan Gratziani will transition from the chief executive officer position effective October 31, 2026. Herbalife Ltd. (NYSE: HLF) announced the transition on August 31, 2026, and stated that it will take effect October 31, 2026.
The announcement concerns an officer role at Herbalife Ltd. and names Gratziani as the executive affected. The stated effective date is October 31, 2026.
Henry C. Wang signed on behalf of Herbalife Ltd. on August 31, 2026. Wang is identified as the company’s chief legal officer and corporate secretary.
FAQs
Q: When will Stephan Gratziani transition from Herbalife’s CEO role?
A: Stephan Gratziani will transition from Herbalife Ltd.’s chief executive officer role effective October 31, 2026. The company announced the timing on August 31, 2026.
Q: What does the filing identify about Herbalife’s CEO transition?
A: The filing identifies October 31, 2026, as the effective date and Stephan Gratziani as the executive transitioning from the CEO role.
Q: Who signed Herbalife Ltd.’s report?
A: Henry C. Wang signed on behalf of Herbalife Ltd. Wang is identified as the company’s chief legal officer and corporate secretary.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.